Suggestions
Amanda Maxwell
European Regulatory Affairs Editor, @Medtech_Insight @Pharma_Intelligence @Informa_Intelligence
Professional Background
Amanda Maxwell is a highly accomplished Medtech regulatory intelligence expert with an impressive career that spans nearly three decades. Her profound understanding of the medical technology sector, particularly in regulatory affairs, has positioned her as a go-to authority within the industry. Amanda's career is marked by her notable capacity to analyze complex regulations and translate them into practical implications for various stakeholders, specifically in the medical device, in vitro diagnostics (IVD), and drug/device combination sectors. She possesses a strong grasp of the evolving landscape of medtech regulations, especially in light of significant events such as Brexit, which has impacted the future of UK/EU medtech regulations.
Throughout her distinguished career, Amanda has built an extensive network, fostering relationships among industry players, regulatory bodies, notified bodies, and influential organizations like the European Parliament, the European Medicines Agency (EMA), and the European Commission. This network is a testament to her commitment to excellence and her status as a leading figure in the field.
In addition to her analytical capabilities, Amanda has demonstrated exceptional proficiency in communication. She has experience as a speaker, moderator, and chair at numerous prestigious conferences in both the EU and the US, which include notable events like the EU Knect 365's MedTech Summits, RMD Berlin 2017, and Brussels 2018. Her engaging speaking style and depth of knowledge enable her to effectively convey intricate regulatory frameworks to diverse audiences, making her a respected figure within the regulatory community.
Education and Achievements
Amanda's educational journey began at Shrewsbury High School, where she laid the foundation for her academic and professional life. She later pursued her passion for languages by studying French and Italian at Royal Holloway, University of London. This educational background has enhanced her ability to engage with international partners and communicate effectively across cultural boundaries.
Over her extensive career, Amanda has amassed a wealth of knowledge in regulatory affairs, consultancy, and regulatory analysis. She has honed her skills in various vital areas, including medical technology, drug/device combinations, classification, and companion diagnostics. Her keen awareness of customer needs, coupled with a strong understanding of deadlines and confidentiality requirements, empowers her to provide invaluable insights that drive strategic decision-making within organizations.
Achievements
Amanda's contributions to the medtech industry are noteworthy and numerous. As the current European Regulatory Affairs Editor at Medtech Insight, part of the Pharma Intelligence group, she plays a pivotal role in disseminating up-to-date regulatory intelligence and insights to professionals across the medical technology field. Her editorial work allows her to shape thought leadership discussions and educate industry stakeholders about emerging regulatory changes.
Prior to her current role, Amanda was the Freelance Regulatory Consultant at Maxwell Medtech Regulatory Consultancy, where she provided tailored advice and strategic guidance to multiple clients navigating the complexities of the medtech regulatory landscape. Furthermore, she served as a Principal Consultant at SFL Regulatory Affairs Consulting in the UK, where her expertise helped organizations meet the rigorous standards required for compliance and market access.
Amanda's previous experience includes her tenure as the European regulatory affairs editor at Clinica, which further enriched her understanding of the industry's dynamics and regulatory challenges.
Overall, Amanda Maxwell is a profound asset to the medical technology sector, and her unwavering commitment to advancing regulatory intelligence and compliance has made a significant impact on the industry. Her expertise, communication skills, and extensive network of contacts contribute to her reputation as a leading authority in medtech regulatory affairs.
